CoMentis
South San Francisco, US · Delaware corporation
Founders & leadership
MD
Michael Detke, MD, PhDExecutive
TK
Terence Kelly, PhDExecutive
DH
Daniel HuntExecutive
Board
RG
Robert G. McNeil, PhDBoard director
FM
Fred MiddletonBoard director
DH
Dennis Henner, PhDBoard director
JL
John L. HigginsBoard director
Reported raises · per SEC filings
Form D private placements$4.5M disclosed across 1 round · 2016
▶$4.5MraisedMar 2016 · 2 investors · PharmaceuticalsRule 506(b)
▶$4.5MraisedMar 2016 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael Detke, MD, PhDExecutive Officer
- Terence Kelly, PhDExecutive Officer, Director
- Robert G. McNeil, PhDDirector
- Daniel HuntExecutive Officer
- Fred MiddletonDirector
- Dennis Henner, PhDDirector
- John L. HigginsDirector
- Offering amount
- $12M
- Amount sold
- $4.5M
- Finders' fees
- $50K
- Placement agents
- Piper Jaffray & Co.
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has CoMentis raised?
- CoMentis has disclosed $4.5M raised across 1 round.
- Where is CoMentis headquartered?
- CoMentis is headquartered in South San Francisco, US.